Bausch Health Companies (BHC) Profit After Tax (2009 - 2026)
Bausch Health Companies (BHC) posted Profit After Tax of $260.0 million for Q2 2026, up 118.17% sequentially from -$1.4 billion in Q1 2026, and up 75.68% YoY from $148.0 million in Q2 2025.
Bausch Health Companies (BHC) Profit After Tax (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Profit After Tax for 18 years, with the latest figure at $260.0 million in Q2 2026.
- Quarterly Profit After Tax rose 75.68% year-over-year to $260.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$1.1 billion (down 1720.59% YoY) and the FY2025 annual result came in at $157.0 million, up 318.06% from the prior year.
- Profit After Tax grew to $260.0 million in Q2 2026 per BHC's latest filing, from -$1.4 billion in the prior quarter.
- Over five years, Profit After Tax peaked at $403.0 million in Q3 2022 and troughed at -$1.4 billion in Q1 2026.
- A 5-year average of -$108.1 million and a median of -$73.0 million in 2022 frame the typical range for Profit After Tax.
- The sharpest annual moves came in 2025 and 2026: Profit After Tax soared 1380.0% in 2025, then slumped 1563.95% in 2026.
- Over 5 years, Profit After Tax stood at -$423.0 million in 2022, then soared by 88.89% to -$47.0 million in 2023, then soared by 308.51% to $98.0 million in 2024, then plunged by 214.29% to -$112.0 million in 2025, then soared by 332.14% to $260.0 million in 2026.
- According to Business Quant data, Profit After Tax over the past three periods registered $260.0 million, -$1.4 billion, and -$112.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Bausch Health Companies | 2.57 Bn | 732.63 Mn | 2.10 Bn | 260.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 260.00 Mn |
| Mar 31, 2026 | -1.43 Bn |
| Dec 31, 2025 | -112.00 Mn |
| Sep 30, 2025 | 179.00 Mn |
| Jun 30, 2025 | 128.00 Mn |
| Mar 31, 2025 | -86.00 Mn |
| Dec 31, 2024 | 98.00 Mn |
| Sep 30, 2024 | -92.00 Mn |
| Jun 30, 2024 | 10.00 Mn |
| Mar 31, 2024 | -64.00 Mn |
| Dec 31, 2023 | -58.00 Mn |
| Sep 30, 2023 | -382.00 Mn |
| Jun 30, 2023 | 26.00 Mn |
| Mar 31, 2023 | -201.00 Mn |
| Dec 31, 2022 | -423.00 Mn |
| Sep 30, 2022 | 399.00 Mn |
| Jun 30, 2022 | -145.00 Mn |
| Mar 31, 2022 | -66.00 Mn |
| Dec 31, 2021 | 80.00 Mn |
| Sep 30, 2021 | 191.00 Mn |